For example, the effect of RA on IL-6 or CRP as mediators can be estimated when trying to identify causal pathways of RA on cardiovascular risk, in which case it is important to consider whether variants are more likely to instrument RA or the mediator. The gene discussed is CRP; the disease is rheumatoid arthritis.